NIIMBL has selected eight new member-led technology and workforce development projects totaling $9.7 million in NIIMBL funding and member co-investment through its Project Call 9.1. Featuring 39 participating organizations, the projects target major industry challenges to advance domestic biopharmaceutical manufacturing capabilities and talent development strategies.
The National Center for Therapeutics Manufacturing at Texas A&M University was selected as the lead for their project:
- Project: Creating a Neurodiverse Talent Pipeline for the Biomanufacturing Industry 2.0
Lead: National Center for Therapeutics Manufacturing (Texas A&M University)
Participants: Janssen, Johnston Community College, Open Biopharma Research and Training Institute, Pfizer, Inc., and University of California, Los AngelesThis project expands the previously NIIMBL-funded NeuroPIPES program beyond Texas to new locations in North Carolina and California, extending opportunities to neurodivergent individuals across the U.S. NeuroPIPES delivers technical and professional skills training that prepares neurodivergent adults for careers in biopharmaceutical manufacturing. The program strengthens industry talent pipelines while addressing the high rates of underemployment among autistic and neurodivergent individuals.
For more information on this project and others involved in this project call, visit https://www.niimbl.org/projects-programs/project-call-9-1/.
